ID   SYN1_HUMAN              Reviewed;         705 AA.
AC   P17600; B1AJQ1; O75825; Q5H9A9;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 3.
DT   28-JAN-2026, entry version 225.
DE   RecName: Full=Synapsin-1;
DE   AltName: Full=Brain protein 4.1;
DE   AltName: Full=Synapsin I;
GN   Name=SYN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=2110562; DOI=10.1016/s0021-9258(19)39008-8;
RA   Suedhof T.C.;
RT   "The structure of the human synapsin I gene and protein.";
RL   J. Biol. Chem. 265:7849-7852(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-125.
RX   PubMed=2118519; DOI=10.1016/s0021-9258(18)77206-2;
RA   Sauerwald A., Hoesche C., Oschwald R., Kilimann M.W.;
RT   "The 5'-flanking region of the synapsin I gene. A G+C-rich, TATA- and CAAT-
RT   less, phylogenetically conserved sequence with cell type-specific promoter
RT   function.";
RL   J. Biol. Chem. 265:14932-14937(1990).
RN   [5]
RP   INVOLVEMENT IN EPILX1.
RX   PubMed=14985377; DOI=10.1136/jmg.2003.013680;
RA   Garcia C.C., Blair H.J., Seager M., Coulthard A., Tennant S., Buddles M.,
RA   Curtis A., Goodship J.A.;
RT   "Identification of a mutation in synapsin I, a synaptic vesicle protein, in
RT   a family with epilepsy.";
RL   J. Med. Genet. 41:183-187(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-551 AND SER-553, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain cortex;
RX   PubMed=15822905; DOI=10.1021/pr0498436;
RA   DeGiorgis J.A., Jaffe H., Moreira J.E., Carlotti C.G. Jr., Leite J.P.,
RA   Pant H.C., Dosemeci A.;
RT   "Phosphoproteomic analysis of synaptosomes from human cerebral cortex.";
RL   J. Proteome Res. 4:306-315(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-551 AND SER-553, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   VARIANTS XLID50 THR-550 AND 555-GLN--ASP-705 DEL, CHARACTERIZATION OF
RP   VARIANTS XLID50 THR-550 AND 555-GLN--ASP-705 DEL, VARIANT ALA-567,
RP   CHARACTERIZATION OF VARIANT ALA-567, INVOLVEMENT IN XLID50, SUBCELLULAR
RP   LOCATION, FUNCTION, AND PHOSPHORYLATION.
RX   PubMed=21441247; DOI=10.1093/hmg/ddr122;
RA   Fassio A., Patry L., Congia S., Onofri F., Piton A., Gauthier J., Pozzi D.,
RA   Messa M., Defranchi E., Fadda M., Corradi A., Baldelli P., Lapointe L.,
RA   St-Onge J., Meloche C., Mottron L., Valtorta F., Khoa Nguyen D.,
RA   Rouleau G.A., Benfenati F., Cossette P.;
RT   "SYN1 loss-of-function mutations in autism and partial epilepsy cause
RT   impaired synaptic function.";
RL   Hum. Mol. Genet. 20:2297-2307(2011).
RN   [9]
RP   INTERACTION WITH SYN2, FUNCTION, AND CHARACTERIZATION OF VARIANT XLID50
RP   555-GLN--ASP-705 DEL.
RX   PubMed=23406870; DOI=10.1093/hmg/ddt071;
RA   Lignani G., Raimondi A., Ferrea E., Rocchi A., Paonessa F., Cesca F.,
RA   Orlando M., Tkatch T., Valtorta F., Cossette P., Baldelli P., Benfenati F.;
RT   "Epileptogenic Q555X SYN1 mutant triggers imbalances in release dynamics
RT   and short-term plasticity.";
RL   Hum. Mol. Genet. 22:2186-2199(2013).
RN   [10]
RP   VARIANT XLID50 TRP-79, AND CHARACTERIZATION OF VARIANT XLID50 TRP-79.
RX   PubMed=28973667; DOI=10.1093/hmg/ddx352;
RA   Guarnieri F.C., Pozzi D., Raimondi A., Fesce R., Valente M.M.,
RA   Delvecchio V.S., Van Esch H., Matteoli M., Benfenati F., D'Adamo P.,
RA   Valtorta F.;
RT   "A novel SYN1 missense mutation in non-syndromic X-linked intellectual
RT   disability affects synaptic vesicle life cycle, clustering and mobility.";
RL   Hum. Mol. Genet. 26:4699-4714(2017).
CC   -!- FUNCTION: Neuronal phosphoprotein that coats synaptic vesicles, and
CC       binds to the cytoskeleton. Acts as a regulator of synaptic vesicles
CC       trafficking, involved in the control of neurotransmitter release at the
CC       pre-synaptic terminal (PubMed:21441247, PubMed:23406870). Also involved
CC       in the regulation of axon outgrowth and synaptogenesis (By similarity).
CC       The complex formed with NOS1 and CAPON proteins is necessary for
CC       specific nitric-oxid functions at a presynaptic level (By similarity).
CC       {ECO:0000250|UniProtKB:O88935, ECO:0000250|UniProtKB:P09951,
CC       ECO:0000269|PubMed:21441247, ECO:0000269|PubMed:23406870}.
CC   -!- SUBUNIT: Homodimer (By similarity). Can form oligomers with SYN2
CC       (PubMed:23406870). Interacts with CAPON. Forms a ternary complex with
CC       NOS1 (By similarity). Isoform Ib interacts with PRNP (By similarity).
CC       {ECO:0000250|UniProtKB:O88935, ECO:0000250|UniProtKB:P09951,
CC       ECO:0000269|PubMed:23406870}.
CC   -!- SUBCELLULAR LOCATION: Synapse {ECO:0000250|UniProtKB:O88935}. Golgi
CC       apparatus {ECO:0000250|UniProtKB:O88935}. Presynapse
CC       {ECO:0000269|PubMed:21441247}. Cytoplasmic vesicle, secretory vesicle,
CC       synaptic vesicle {ECO:0000250|UniProtKB:P09951}. Note=Dissociates from
CC       synaptic vesicles and redistributes into the axon during action
CC       potential firing, in a step that precedes fusion of vesicles with the
CC       plasma membrane. Reclusters to presynapses after the cessation of
CC       synaptic activity. {ECO:0000250|UniProtKB:P09951}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=IA;
CC         IsoId=P17600-1; Sequence=Displayed;
CC       Name=IB;
CC         IsoId=P17600-2; Sequence=VSP_006316, VSP_006317;
CC   -!- DOMAIN: The A region binds phospholipids with a preference for
CC       negatively charged species. {ECO:0000250}.
CC   -!- PTM: Substrate of different protein kinases. Phosphorylated by CaMK2
CC       and MAPK1 (PubMed:21441247). Phosphorylation, including phosphorylation
CC       at Ser-9, promotes synapsin-1 dissociation from synaptic vesicles,
CC       regulates its rate of dispersion, and controls the kinetics of vesicle
CC       pool turnover and neurotransmitter release (By similarity)
CC       (PubMed:21441247). {ECO:0000250|UniProtKB:P09951,
CC       ECO:0000269|PubMed:21441247}.
CC   -!- DISEASE: Epilepsy, X-linked 1, with variable learning disabilities and
CC       behavior disorders (EPILX1) [MIM:300491]: A neurologic disorder
CC       characterized by variable combinations of epilepsy, learning
CC       difficulties, macrocephaly, and aggressive behavior.
CC       {ECO:0000269|PubMed:14985377}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Intellectual developmental disorder, X-linked 50 (XLID50)
CC       [MIM:300115]: A form of intellectual disability, a disorder
CC       characterized by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period. Intellectual deficiency is
CC       the only primary symptom of non-syndromic X-linked forms, while
CC       syndromic forms present with associated physical, neurological and/or
CC       psychiatric manifestations. {ECO:0000269|PubMed:21441247,
CC       ECO:0000269|PubMed:23406870, ECO:0000269|PubMed:28973667}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the synapsin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M58378; AAC41930.1; -; Genomic_DNA.
DR   EMBL; M58321; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58341; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58351; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58353; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58359; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58371; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58372; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58373; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58374; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58375; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58376; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58377; AAC41930.1; JOINED; Genomic_DNA.
DR   EMBL; M58378; AAC41931.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M58321; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58341; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58351; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58353; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58359; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58371; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58372; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58373; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58374; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58375; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58376; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; M58377; AAC41931.1; JOINED; Genomic_DNA.
DR   EMBL; AL009172; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84466; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471164; EAW59313.1; -; Genomic_DNA.
DR   EMBL; M55301; AAA60608.1; -; Genomic_DNA.
DR   CCDS; CCDS14280.1; -. [P17600-1]
DR   CCDS; CCDS35233.1; -. [P17600-2]
DR   PIR; A35363; A35363.
DR   RefSeq; NP_008881.2; NM_006950.3. [P17600-1]
DR   RefSeq; NP_598006.1; NM_133499.2. [P17600-2]
DR   AlphaFoldDB; P17600; -.
DR   SMR; P17600; -.
DR   BioGRID; 112719; 43.
DR   CORUM; P17600; -.
DR   FunCoup; P17600; 257.
DR   IntAct; P17600; 28.
DR   MINT; P17600; -.
DR   STRING; 9606.ENSP00000295987; -.
DR   DrugBank; DB02930; Adenosine 5'-[gamma-thio]triphosphate.
DR   GlyCosmos; P17600; 13 sites, 1 glycan.
DR   GlyGen; P17600; 14 sites, 1 O-linked glycan (5 sites).
DR   iPTMnet; P17600; -.
DR   PhosphoSitePlus; P17600; -.
DR   SwissPalm; P17600; -.
DR   BioMuta; SYN1; -.
DR   DMDM; 73920800; -.
DR   jPOST; P17600; -.
DR   MassIVE; P17600; -.
DR   PaxDb; 9606-ENSP00000295987; -.
DR   PeptideAtlas; P17600; -.
DR   ProteomicsDB; 53494; -. [P17600-1]
DR   ProteomicsDB; 53495; -. [P17600-2]
DR   ABCD; P17600; 1 sequenced antibody.
DR   Antibodypedia; 403; 1094 antibodies from 46 providers.
DR   DNASU; 6853; -.
DR   Ensembl; ENST00000295987.13; ENSP00000295987.7; ENSG00000008056.15. [P17600-1]
DR   Ensembl; ENST00000340666.5; ENSP00000343206.4; ENSG00000008056.15. [P17600-2]
DR   GeneID; 6853; -.
DR   KEGG; hsa:6853; -.
DR   MANE-Select; ENST00000295987.13; ENSP00000295987.7; NM_006950.3; NP_008881.2.
DR   UCSC; uc004did.4; human. [P17600-1]
DR   AGR; HGNC:11494; -.
DR   ClinPGx; PA36276; -.
DR   CTD; 6853; -.
DR   DisGeNET; 6853; -.
DR   GeneCards; SYN1; -.
DR   HGNC; HGNC:11494; SYN1.
DR   HPA; ENSG00000008056; Tissue enriched (brain).
DR   MalaCards; SYN1; -.
DR   MIM; 300115; phenotype.
DR   MIM; 300491; phenotype.
DR   MIM; 313440; gene.
DR   OpenTargets; ENSG00000008056; -.
DR   Orphanet; 85294; X-linked epilepsy-learning disabilities-behavior disorders syndrome.
DR   VEuPathDB; HostDB:ENSG00000008056; -.
DR   eggNOG; KOG3895; Eukaryota.
DR   GeneTree; ENSGT00940000161978; -.
DR   HOGENOM; CLU_010582_3_0_1; -.
DR   InParanoid; P17600; -.
DR   OMA; QWITEVS; -.
DR   OrthoDB; 10249572at2759; -.
DR   PAN-GO; P17600; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; P17600; -.
DR   PathwayCommons; P17600; -.
DR   Reactome; R-HSA-181429; Serotonin Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-212676; Dopamine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-9662360; Sensory processing of sound by inner hair cells of the cochlea.
DR   SignaLink; P17600; -.
DR   SIGNOR; P17600; -.
DR   Agora; ENSG00000008056; Agora Nominated Target for Alzheimer's Disease.
DR   BioGRID-ORCS; 6853; 11 hits in 775 CRISPR screens.
DR   CD-CODE; 0D48A13A; Synthetic Condensate 000121.
DR   CD-CODE; 84137BFC; Synthetic Condensate 000112.
DR   CD-CODE; C2ED57FB; Synthetic Condensate 000110.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   CD-CODE; FF4E772B; Synthetic Condensate 000083.
DR   ChiTaRS; SYN1; human.
DR   GeneWiki; Synapsin_I; -.
DR   GenomeRNAi; 6853; -.
DR   Pharos; P17600; Tbio.
DR   PRO; PR:P17600; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P17600; protein.
DR   Bgee; ENSG00000008056; Expressed in right frontal lobe and 126 other cell types or tissues.
DR   ExpressionAtlas; P17600; baseline and differential.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0005856; C:cytoskeleton; IDA:ARUK-UCL.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0098850; C:extrinsic component of synaptic vesicle membrane; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0098793; C:presynapse; IDA:UniProtKB.
DR   GO; GO:0048786; C:presynaptic active zone; IEA:Ensembl.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IEA:Ensembl.
DR   GO; GO:0008021; C:synaptic vesicle; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IBA:GO_Central.
DR   GO; GO:0000795; C:synaptonemal complex; IEA:Ensembl.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IEA:Ensembl.
DR   GO; GO:0106006; F:cytoskeletal protein-membrane anchor activity; TAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0007269; P:neurotransmitter secretion; IEA:Ensembl.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0098693; P:regulation of synaptic vesicle cycle; IEA:Ensembl.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IMP:UniProtKB.
DR   GO; GO:0050808; P:synapse organization; IBA:GO_Central.
DR   GO; GO:0097091; P:synaptic vesicle clustering; IBA:GO_Central.
DR   FunFam; 3.30.1490.20:FF:000008; Synapsin I; 1.
DR   FunFam; 3.30.470.20:FF:000042; Synapsin III; 1.
DR   FunFam; 3.40.50.20:FF:000008; Synapsin III; 1.
DR   Gene3D; 3.40.50.20; -; 1.
DR   Gene3D; 3.30.1490.20; ATP-grasp fold, A domain; 1.
DR   Gene3D; 3.30.470.20; ATP-grasp fold, B domain; 1.
DR   InterPro; IPR013815; ATP_grasp_subdomain_1.
DR   InterPro; IPR016185; PreATP-grasp_dom_sf.
DR   InterPro; IPR001359; Synapsin.
DR   InterPro; IPR020898; Synapsin_ATP-bd_dom.
DR   InterPro; IPR019735; Synapsin_CS.
DR   InterPro; IPR019736; Synapsin_P_site.
DR   InterPro; IPR020897; Synapsin_pre-ATP-grasp_dom.
DR   PANTHER; PTHR10841; SYNAPSIN; 1.
DR   PANTHER; PTHR10841:SF24; SYNAPSIN-1; 1.
DR   Pfam; PF02078; Synapsin; 1.
DR   Pfam; PF02750; Synapsin_C; 1.
DR   Pfam; PF10581; Synapsin_N; 1.
DR   PRINTS; PR01368; SYNAPSIN.
DR   SUPFAM; SSF56059; Glutathione synthetase ATP-binding domain-like; 1.
DR   SUPFAM; SSF52440; PreATP-grasp domain; 1.
DR   PROSITE; PS00415; SYNAPSIN_1; 1.
DR   PROSITE; PS00416; SYNAPSIN_2; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; Alternative splicing; Cell projection; Cytoplasmic vesicle;
KW   Disease variant; Epilepsy; Glycoprotein; Golgi apparatus;
KW   Intellectual disability; Methylation; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Repeat; Synapse.
FT   CHAIN           1..705
FT                   /note="Synapsin-1"
FT                   /id="PRO_0000183018"
FT   REGION          1..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1..28
FT                   /note="A"
FT   REGION          29..112
FT                   /note="B; linker"
FT   REGION          113..420
FT                   /note="C; actin-binding and synaptic-vesicle binding"
FT   REGION          418..689
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          421..655
FT                   /note="D; Pro-rich linker"
FT   REGION          656..705
FT                   /note="E"
FT   COMPBIAS        28..37
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        38..69
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        453..473
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        489..499
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        509..537
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        541..552
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        553..590
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        608..622
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        660..670
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         9
FT                   /note="Phosphoserine; by CaMK1 and PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P09951"
FT   MOD_RES         39
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         62
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P09951"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P09951"
FT   MOD_RES         312
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         427
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         430
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         432
FT                   /note="Phosphoserine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         436
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P09951"
FT   MOD_RES         438
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         476
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         534
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         547
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         551
FT                   /note="Phosphoserine; by PDPK1"
FT                   /evidence="ECO:0007744|PubMed:15822905,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         553
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:15822905,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         556
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         568
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000250|UniProtKB:P17599"
FT   MOD_RES         605
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000250|UniProtKB:P17599"
FT   MOD_RES         622
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         663
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         665
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         679
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   MOD_RES         683
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88935"
FT   CARBOHYD        55
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        87
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        96
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        103
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        261
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        432
FT                   /note="O-linked (GlcNAc) serine; alternate"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        526
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        564
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        578
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         661..669
FT                   /note="NKSQSLTNA -> KASPAQAQP (in isoform IB)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006316"
FT   VAR_SEQ         670..705
FT                   /note="Missing (in isoform IB)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006317"
FT   VARIANT         79
FT                   /note="S -> W (in XLID50; results in reduced synaptic
FT                   vesicle mobility, increased clustering of synaptic vesicles
FT                   at presynatptic terminals and increased frequency of
FT                   miniature excitatory postsynaptic currents;
FT                   dbSNP:rs2057941303)"
FT                   /evidence="ECO:0000269|PubMed:28973667"
FT                   /id="VAR_086821"
FT   VARIANT         550
FT                   /note="A -> T (in XLID50; uncertain significance; no effect
FT                   on phosphorylation by CaMK2 and MAPK1; has no effect on
FT                   axon elongation when tested in SYN1-knockout mouse neurons;
FT                   slightly reduced protein targeting to presynapse;
FT                   dbSNP:rs397514680)"
FT                   /evidence="ECO:0000269|PubMed:21441247"
FT                   /id="VAR_086822"
FT   VARIANT         555..705
FT                   /note="Missing (in XLID50; affects excitatory and
FT                   inhibitory synaptic transmission leading to neuronal
FT                   hyperexcitability; fails to rescue defective synaptic
FT                   vesicle exocytosis in SYN1-knockout mouse neurons; results
FT                   in severely decreased phosphorylation by CaMK2 and MAPK1;
FT                   results in delayed axon elongation when tested in
FT                   SYN1-knockout mouse neurons; severely reduced interaction
FT                   with SYN2; has no effect on protein targeting to
FT                   presynapse)"
FT                   /evidence="ECO:0000269|PubMed:21441247,
FT                   ECO:0000269|PubMed:23406870"
FT                   /id="VAR_086823"
FT   VARIANT         567
FT                   /note="T -> A (no effect on phosphorylation by CaMK2 and
FT                   MAPK1; has no effect on axon elongation when tested in
FT                   SYN1-knockout mouse neurons; slightly reduced protein
FT                   targeting to presynapse; dbSNP:rs200533370)"
FT                   /evidence="ECO:0000269|PubMed:21441247"
FT                   /id="VAR_086824"
FT   CONFLICT        138
FT                   /note="E -> G (in Ref. 1; AAC41930/AAC41931)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        631
FT                   /note="R -> A (in Ref. 1; AAC41930/AAC41931)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   705 AA;  74111 MW;  BE4CE46C942300B0 CRC64;
     MNYLRRRLSD SNFMANLPNG YMTDLQRPQP PPPPPGAHSP GATPGPGTAT AERSSGVAPA
     ASPAAPSPGS SGGGGFFSSL SNAVKQTTAA AAATFSEQVG GGSGGAGRGG AASRVLLVID
     EPHTDWAKYF KGKKIHGEID IKVEQAEFSD LNLVAHANGG FSVDMEVLRN GVKVVRSLKP
     DFVLIRQHAF SMARNGDYRS LVIGLQYAGI PSVNSLHSVY NFCDKPWVFA QMVRLHKKLG
     TEEFPLIDQT FYPNHKEMLS STTYPVVVKM GHAHSGMGKV KVDNQHDFQD IASVVALTKT
     YATAEPFIDA KYDVRVQKIG QNYKAYMRTS VSGNWKTNTG SAMLEQIAMS DRYKLWVDTC
     SEIFGGLDIC AVEALHGKDG RDHIIEVVGS SMPLIGDHQD EDKQLIVELV VNKMAQALPR
     QRQRDASPGR GSHGQTPSPG ALPLGRQTSQ QPAGPPAQQR PPPQGGPPQP GPGPQRQGPP
     LQQRPPPQGQ QHLSGLGPPA GSPLPQRLPS PTSAPQQPAS QAAPPTQGQG RQSRPVAGGP
     GAPPAARPPA SPSPQRQAGP PQATRQTSVS GPAPPKASGA PPGGQQRQGP PQKPPGPAGP
     TRQASQAGPV PRTGPPTTQQ PRPSGPGPAG RPKPQLAQKP SQDVPPPATA AAGGPPHPQL
     NKSQSLTNAF NLPEPAPPRP SLSQDEVKAE TIRSLRKSFA SLFSD
//
